1
|
Clinical outcomes and adherence to medications measured by claims data in patients with diabetes.
|
Diabetes Care
|
2004
|
3.31
|
2
|
Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma.
|
J Allergy Clin Immunol
|
2004
|
2.44
|
3
|
Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.
|
Inflamm Bowel Dis
|
2007
|
2.03
|
4
|
FDA drug prescribing warnings: is the black box half empty or half full?
|
Pharmacoepidemiol Drug Saf
|
2006
|
1.83
|
5
|
Monitoring of drugs with a narrow therapeutic range in ambulatory care.
|
Am J Manag Care
|
2006
|
1.60
|
6
|
Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs.
|
J Manag Care Pharm
|
2006
|
1.46
|
7
|
Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients.
|
Ann Pharmacother
|
2006
|
1.42
|
8
|
Reducing the health risks of diabetes: how self-determination theory may help improve medication adherence and quality of life.
|
Diabetes Educ
|
2009
|
1.36
|
9
|
Inconsistencies in patient perceptions and observer ratings of shared decision making: the case of colorectal cancer screening.
|
Patient Educ Couns
|
2010
|
1.35
|
10
|
The use of QALYs in clinical and patient decision-making: issues and prospects.
|
Value Health
|
2009
|
1.32
|
11
|
Laboratory monitoring of drugs at initiation of therapy in ambulatory care.
|
J Gen Intern Med
|
2005
|
1.23
|
12
|
Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001.
|
J Am Geriatr Soc
|
2005
|
1.22
|
13
|
Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control.
|
Med Care
|
2007
|
1.20
|
14
|
Prioritization of evidence-based preventive health services during periodic health examinations.
|
Am J Prev Med
|
2012
|
1.14
|
15
|
Adherence analysis using visual analog scale versus claims-based estimation.
|
Ann Pharmacother
|
2007
|
1.12
|
16
|
The utility of administrative data for measuring adherence to cancer surveillance care guidelines.
|
Med Care
|
2007
|
1.12
|
17
|
Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project.
|
Am J Epidemiol
|
2014
|
1.11
|
18
|
Pharmacy and medical claims data identified migraine sufferers with high specificity but modest sensitivity.
|
J Clin Epidemiol
|
2004
|
1.05
|
19
|
Using claims-based measures to predict performance status score in patients with lung cancer.
|
Cancer
|
2010
|
1.05
|
20
|
Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications?
|
Med Care
|
2006
|
1.04
|
21
|
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
|
Pharmacoepidemiol Drug Saf
|
2007
|
1.04
|
22
|
Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy.
|
Lung Cancer
|
2012
|
0.98
|
23
|
Determining the value of disease management programs.
|
Jt Comm J Qual Saf
|
2003
|
0.95
|
24
|
Patient-rated importance and receipt of information for colorectal cancer screening.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.95
|
25
|
Frequency of high-risk use of QT-prolonging medications.
|
Pharmacoepidemiol Drug Saf
|
2006
|
0.94
|
26
|
Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer.
|
Lung Cancer
|
2011
|
0.92
|
27
|
Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees.
|
J Am Geriatr Soc
|
2005
|
0.90
|
28
|
A standardized relative resource cost model for medical care: application to cancer control programs.
|
J Natl Cancer Inst Monogr
|
2013
|
0.88
|
29
|
The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system.
|
J Natl Cancer Inst Monogr
|
2013
|
0.86
|
30
|
Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
|
Ann Pharmacother
|
2007
|
0.85
|
31
|
Differences in the reporting of care-related patient injuries to existing reporting systems.
|
Jt Comm J Qual Saf
|
2003
|
0.83
|
32
|
Racial disparities in lipid control in patients with diabetes.
|
Am J Manag Care
|
2012
|
0.82
|
33
|
Sexual health discussions with older adult patients during periodic health exams.
|
J Sex Med
|
2014
|
0.81
|
34
|
Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study.
|
J Am Pharm Assoc (2003)
|
2014
|
0.81
|
35
|
Factors associated with patient reports of positive physician relational communication.
|
Patient Educ Couns
|
2012
|
0.80
|
36
|
Contraceptive insurance mandates and consistent contraceptive use among privately insured women.
|
Med Care
|
2012
|
0.80
|
37
|
Time to pharmacotherapy change in response to elevated HbA1c test results.
|
Curr Med Res Opin
|
2006
|
0.78
|
38
|
Who Must We Target Now to Minimize Future Cardiovascular Events and Total Mortality?: Lessons From the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) Cohort Study.
|
Circ Cardiovasc Qual Outcomes
|
2015
|
0.77
|
39
|
Trends in lipid management among patients with diabetes.
|
Endocr Pract
|
2006
|
0.77
|
40
|
The Role of Research in Integrated Health Care Systems: The HMO Research Network.
|
Perm J
|
2004
|
0.75
|
41
|
Erratum. Response to Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005-2011. Diabetes Care 2016;39:363-370. Diabetes Care 2017;40:e26.
|
Diabetes Care
|
2017
|
0.75
|
42
|
Patient and Physician Race and the Allocation of Time and Patient Engagement Efforts to Mental Health Discussions in Primary Care: An Observational Study of Audiorecorded Periodic Health Examinations.
|
J Ambul Care Manage
|
2017
|
0.75
|